By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sorrento Therapeutics, Inc. 

6042 Cornerstone Court W,

San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a



Company News
ARK Animal Health, A Subsidiary Of Sorrento (SRNE), Announces Submission Of Two Major Technical Sections Of A New Animal Drug Application 9/27/2016 10:08:34 AM
Sorrento (SRNE) Appoints Miranda Toledano As Executive Vice President Of Corporate Development, And President Of LA Cell 9/13/2016 6:53:54 AM
Sorrento (SRNE) To Present At Two Upcoming Conferences In New York City 8/31/2016 10:50:44 AM
Sorrento (SRNE)'s Subsidiary Scintilla Pharma Snapped Up Semnur for $200 Million 8/16/2016 6:59:22 AM
Former Celgene (CELG) Chief Exec Joins Sorrento (SRNE) as Chief Medical Officer and President of Clinical Development 8/15/2016 7:44:15 AM
Sorrento (SRNE) Subsidiary Pays $70 Million in Stock for Scilex 8/8/2016 7:49:13 AM
Sorrento (SRNE) To Form Joint Venture With CHA Biotech To Develop And Commercialize Natural Killer Cell Therapies 8/2/2016 7:20:53 AM
Sorrento (SRNE) Announces The Appointment Of Dr. Yue Alexander Wu To Its Board Of Directors 8/1/2016 9:38:25 AM
San Diego's Sorrento (SRNE) Forges €735 Million Immuno-Onco Tie-Up with Servier 7/11/2016 7:24:41 AM
Week In Review: Sorrento (SRNE) Raises $150 Million From China Investors 6/13/2016 8:48:53 AM